These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31262129)

  • 21. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of drug-coated balloons in the treatment of
    Zhang M; Yong J; Zhou Y; Zhang M; Song X; Qiao S; Wang L; Tong Q; Zhang L; Shi B
    Ann Transl Med; 2022 Apr; 10(8):445. PubMed ID: 35571396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
    Waksman R; Piegari GN; Kabour A; Cannon L; Wang J; Adams G; Solankhi N; Smeglin A; Kereiakes DJ; Leiboff R; Spad MA; Torguson R; Chandra N; Bastian R; DeGroot J; Kayo MW; Stoll HP; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2017; 18(7):475-481. PubMed ID: 28923692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study.
    Pan L; Lu W; Han Z; Pan S; Wang X; Shan Y; Wang X; Zheng X; Li R; Zhou Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
    Clin Res Cardiol; 2022 Jul; 111(7):732-741. PubMed ID: 34313800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiographic and Clinical Outcomes After Stent-less Coronary Intervention Using Rotational Atherectomy and Drug-Coated Balloon in Patients with De Novo Lesions.
    Shiraishi J; Kataoka E; Ozawa T; Shiraga A; Ikemura N; Matsubara Y; Nishimura T; Ito D; Kojima A; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Cardiovasc Revasc Med; 2020 May; 21(5):647-653. PubMed ID: 31494063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of
    Jun EJ; Shin ES; Teoh EV; Bhak Y; Yuan SL; Chu CM; Garg S; Liew HB
    Front Cardiovasc Med; 2022; 9():821380. PubMed ID: 35498010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry.
    Mitomo S; Jabbour RJ; Mangieri A; Ancona M; Regazzoli D; Tanaka A; Giannini F; Carlino M; Montorfano M; Chieffo A; Latib A; Colombo A
    Int J Cardiol; 2018 Jul; 263():17-23. PubMed ID: 29685691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque.
    Zhang YB; Liu HD; Xing JH; Chen BW; Zhao YY; Gu HP; Tao HL
    Clin Appl Thromb Hemost; 2022; 28():10760296221130063. PubMed ID: 36198017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-coated balloon versus drug-eluting stent for treating de novo coronary lesions in large vessels: a meta-analysis of clinical trials.
    Lin Y; Sun X; Liu H; Pang X; Dong S
    Herz; 2021 Jun; 46(3):269-276. PubMed ID: 32468141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study.
    Latib A; Agostoni P; Dens J; Patterson M; Lancellotti P; Tam FCC; Schotborgh C; Kedhi E; Stella P; Shen C; Wetzels G; Testa L;
    J Invasive Cardiol; 2021 Nov; 33(11):E863-E869. PubMed ID: 34433695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels.
    Rosenberg M; Waliszewski M; Krackhardt F; Chin K; Wan Ahmad WA; Caramanno G; Milazzo D; Nuruddin AA; Liew HB; Maskon O; Bento A; Macia JC; Frey N
    J Interv Cardiol; 2019; 2019():6548696. PubMed ID: 31772539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes of drug-coated balloon versus drug-eluting stent for
    Lin L; Lu W; Wang X; Pan L; Wang X; Zheng X; Li R; Shan Y; Peng M; Qiu C
    Front Cardiovasc Med; 2023; 10():982880. PubMed ID: 36950290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Good efficacy of drug-eluting balloons in a mixed population of patients with coronary artery disease.
    Cuculi F; Young M; Beeler R; Schoenenberger AW; Erne P
    J Invasive Cardiol; 2012 Apr; 24(4):151-3. PubMed ID: 22477748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
    Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
    Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.